Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1,064.19 |
| Open | 1,067.54 |
| Bid | 1,077.48 x 100 |
| Ask | 1,079.50 x 100 |
| Day's range | 1,067.54 - 1,091.31 |
| 52-week range | 726.12 - 1,106.16 |
| Volume | |
| Avg. volume | 437,650 |
| Market cap | 118.85B |
| Beta (5Y monthly) | 0.13 |
| PE ratio (TTM) | 31.87 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Most readers would already be aware that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased significantly by 20...
- Zacks
Regeneron (REGN) Earnings Expected to Grow: Should You Buy?
Regeneron (REGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Regeneron (REGN) to Report Q2 Earnings: What's in the Cards?
Investors' focus is likely to be on the performance of Dupixent and the uptake of Eylea HD when Regeneron (REGN) reports second-quarter 2024 results.
© 2024 Yahoo. All rights reserved.